Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Ropivacaine Dose for Labor Analgesia via Double Dural Puncture Epidural Technique
NCT07882004Not yet recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Nov 2026
- Primary completion
- Mar 2027
01
Overview
Open-label, single-arm trial of ropivacaine in labor pain, sponsored by General Hospital of Ningxia Medical University. Primary endpoint: 90% Effective Dose of Ropivacaine. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT07882004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07882004.